2D MXenes for controlled releases of therapeutic proteins. Issue 4 (13th November 2022)

• Record Type: Journal Article
• Authors: Seitak, Aibobek; Shanti, Aya; Al Adem, Kenana; Farid, Nouran; Luo, Shaohong; Iskandarov, Javad; Karanikolos, Georgios N.; Liao, Kin; Chan, Vincent; Lee, Sungmun
• Is Part Of: Journal of biomedical materials research. Volume 111:Issue 4(2023)
• Page Start: 514
• Page End: 526
• Publication Date: 2022-11-13
• Subjects: catalase -- cytotoxicity -- drug delivery -- MXene -- therapeutic proteins; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/jbm.a.37469
• Languages: English
• ISSNs: 1549-3296

Abstract

Abstract: MXenes belong to a new class of two dimensional (2D) functional nanomaterials, mainly encompassing transition‐metal carbides, nitrides and carbonitrides, with unique physical, chemical, electronic and mechanical properties for various emerging applications across different fields. To date, the potentials of MXenes for biomedical application such as drug delivery have not been thoroughly explored due to the lack of information on their biocompatibility, cytotoxicity and biomolecule‐surface interaction. In this study, we developed novel drug delivery system from MXene for the controlled release of a model therapeutic protein. First, the structural, chemical and morphological properties of as synthesized MXenes were probed with electron microscopy and X‐ray diffraction. Second, the potential cytotoxicity of MXene toward the proliferation and cell morphology of murine macrophages (RAW 264.7) were evaluated with MTT assays and electron microscopy, respectively. Moreover, the drug loading capacities and sustained release capabilities of MXene were assessed in conjunction with machine learning approaches. Our results demonstrated that MXene did not significantly induce cellular toxicity at any concentration below 1 mg/ml which is within the range for effective dose of drug delivery vehicle. Most importantly, MXene was efficiently loaded with FITC‐catalase for subsequently achieving controlled release under different pHs. The release profiles of catalase from MXene showed higher initial rate under basic buffer (pH 9) compared to that in physiological (pH 7.4) and acidic buffers (pH 2). Taken together, the results of this study lead to a fundamental advancement toward the use of MXene as a nanocarrier for therapeutic proteins in drug delivery applications.